KeyBanc raised the firm’s price target on Oracle (ORCL) to $200 from $190 and keeps an Overweight rating on the shares. Oracle has seen slight downward consensus revisions since others have reported, and consensus expectations for calendar year 2025 are being tempered to end the year, the analyst tells investors in a research note. The most acceleration is baked into consensus expectations for Oracle, the firm says.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Cigna drops pursuit of Humana: Morning Buzz
- McKesson, Oracle among finalists looking to buy Veradigm, Axios reports
- Hackett Group price target raised to $32 from $30 at Craig-Hallum
- Rimini Street continues to suspend guidance amid ongoing litigation with Oracle
- Oracle (NYSE:ORCL) Taps Both Healthcare and AI Markets with New EHR